Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment (Q38063968)

28 August 2017

1 reference

title

Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment (English)

1 reference

Extraintestinal Pathogenic Escherichia coli

28 August 2017

antimicrobial resistance

1 reference

based on heuristic

inferred from title

1 reference

1 reference

Johann D D Pitout

1

1 reference

PubMed ID

23199402

28 August 2017

language of work or name

1 reference

1 October 2012

1 reference

Expert Review of Anti-infective Therapy

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

10

1 reference

28 August 2017

1165-1176

1 reference

Pathogenic Escherichia coli

28 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Virulence factors of septicemic Escherichia coli strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Origins and virulence mechanisms of uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The epidemiology of urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

21 January 2018

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Global spread of Carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Multilocus sequence typing: Data analysis in clinical microbiology and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

New Delhi metallo-beta-lactamase from traveler returning to Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The CTX-M beta-lactamase pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Escherichia coli carrying the blaCTX-M-15 gene of ST648.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Plasmid-determined AmpC-type beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Detection of plasmid-mediated class C beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

21 January 2018

Class A carbapenemases

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Carbapenemases: molecular diversity and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Dissemination of the New Delhi metallo-β-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in north India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

The emerging NDM carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Global spread of New Delhi metallo-β-lactamase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Spread of OXA-48-encoding plasmid in Turkey and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Genetic features of the widespread plasmid coding for the carbapenemase OXA-48.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Identification and screening of carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Overview of nosocomial infections caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Clinical significance of extended-spectrum beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Multidrug-resistant Gram-negative bacteria: how to treat and for how long

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.110

21 January 2018

Identifiers

DOI

10.1586/ERI.12.110

1 reference

28 August 2017

1 reference

PubMed ID

23199402